Emeis (WBO:ORP2) Piotroski F-Score: 5 (As of Jun. 26, 2026) — Near Median


WBO:ORP2 Emeis WBO:ORP2
46 GF Score
Price €14.21
GF Value €9.20
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Emeis Piotroski F-Score?

Emeis WBO:ORP2 +2.01% 46 Piotroski F-Score is 5 as of Jun. 26, 2026, which is at its 10-year median of 5.00. GuruFocus rates WBO:ORP2 with a GF Score™ of 46/100 and a GF Value™ of €9.20 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 652 Healthcare Providers & Services companies, Emeis ranks better than 54.6% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Emeis has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Emeis's Piotroski F-Score or its related term are showing as below:

WBO:ORP2' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 7
Current: 5

During the past 13 years, the highest Piotroski F-Score of Emeis was 7. The lowest was 4. And the median was 5.

Emeis  (WBO:ORP2) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Emeis Piotroski F-Score Related Terms


Emeis Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Emeis's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emeis Piotroski F-Score Chart

Emeis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 5.00 4.00 5.00

Emeis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 4.00 0.00 5.00

WBO:ORP2 vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Emeis's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Emeis Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Emeis's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Emeis's Piotroski F-Score falls into.


WBO:ORP2
46GF Score
Emeis WBO:ORP2
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was €-298 Mil.
Cash Flow from Operations was €680 Mil.
Revenue was €5,895 Mil.
Gross Profit was €4,761 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (13408.585 + 12653.671) / 2 = €13031.128 Mil.
Total Assets at the begining of this year (Dec24) was €13,409 Mil.
Long-Term Debt & Capital Lease Obligation was €7,835 Mil.
Total Current Assets was €1,737 Mil.
Total Current Liabilities was €2,732 Mil.
Net Income was €-412 Mil.

Revenue was €5,636 Mil.
Gross Profit was €4,509 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (13908 + 13408.585) / 2 = €13658.2925 Mil.
Total Assets at the begining of last year (Dec23) was €13,908 Mil.
Long-Term Debt & Capital Lease Obligation was €8,068 Mil.
Total Current Assets was €1,880 Mil.
Total Current Liabilities was €2,623 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Emeis's current Net Income (TTM) was -298. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Emeis's current Cash Flow from Operations (TTM) was 680. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=-298.398/13408.585
=-0.02225425

ROA (Last Year)=Net Income/Total Assets (Dec23)
=-412.065/13908
=-0.02962791

Emeis's return on assets of this year was -0.02225425. Emeis's return on assets of last year was -0.02962791. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Emeis's current Net Income (TTM) was -298. Emeis's current Cash Flow from Operations (TTM) was 680. ==> 680 > -298 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=7835.383/13031.128
=0.60128202

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=8067.791/13658.2925
=0.59068811

Emeis's gearing of this year was 0.60128202. Emeis's gearing of last year was 0.59068811. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=1736.817/2732.455
=0.63562511

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=1880.041/2623.409
=0.71664045

Emeis's current ratio of this year was 0.63562511. Emeis's current ratio of last year was 0.71664045. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Emeis's number of shares in issue this year was 162.789. Emeis's number of shares in issue last year was 159.062. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4761.109/5895.389
=0.80759879

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4509.38/5635.8
=0.8001313

Emeis's gross margin of this year was 0.80759879. Emeis's gross margin of last year was 0.8001313. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=5895.389/13408.585
=0.43967272

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=5635.8/13908
=0.40522002

Emeis's asset turnover of this year was 0.43967272. Emeis's asset turnover of last year was 0.40522002. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+1+1+0+0+0+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Emeis has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Emeis (WBO:ORP2) has a Piotroski F-Score of 5 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Emeis and its competitors. This is near median its historical median of 5.00. Over the past decade, Emeis' Piotroski F-Score has ranged from 4.00 to 7.00. According to the industry distribution chart, Emeis ranks #296 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 45.4%.
Is Emeis' Piotroski F-Score too high?
Emeis' current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 7.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Emeis' value of 5 is 0% at this industry median. Based on the distribution chart, Emeis ranks #296 out of 652 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Emeis has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Emeis' Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Emeis ranks #296 out of 652 companies for Piotroski F-Score. This puts Emeis in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Emeis' value of 5 is 0% at this benchmark. Historically, Emeis' own Piotroski F-Score has ranged from 4.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Emeis has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Emeis's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Emeis and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emeis's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emeis stock overvalued right now?
Based on GuruFocus' analysis, Emeis (WBO:ORP2) is currently considered Significantly Overvalued. The stock's GF Value™ is €9.20, compared to a current price of €14.21 — trading 54.5% above its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Emeis' overall GF Score™ is 46/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Emeis (WBO:ORP2), the current Piotroski F-Score is 5 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Emeis (WBO:ORP2) Overvalued in 2026?

Based on GuruFocus' analysis, Emeis stock appears to be overvalued. The current stock price of €14.21 is trading 54.5% above its estimated GF Value™ of €9.20. GuruFocus considers Emeis to be Significantly Overvalued.

Key valuation signals for WBO:ORP2:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: €9.20 vs. price of €14.21 (54.5% above fair value)
  • GF Score™: 46/100 with 8 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#296 of 652)

No single metric tells the full story. See the WBO:ORP2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Emeis Business Description

Address 12, Rue Jean Jaures, CS 10032, Puteaux Cedex, Paris, FRA, 92 813
Emeis operates a comprehensive care offering of mental health clinics and medical and rehabilitation care, retirement homes, assisted living and home care.
46GF Score

Get the complete analysis for WBO:ORP2

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.21
Price
€9.20
GF Value